Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

BTIG Sticks to Their Buy Rating for Alcon (ALC)

Tipranks - Tipranks - Sat Feb 21, 11:00AM CST

In a report released on February 18, Ryan Zimmerman from BTIG maintained a Buy rating on Alcon, with a price target of $91.00. The company’s shares opened today at CHF61.68.

President's Day Sale - 70% Off

Zimmerman covers the Healthcare sector, focusing on stocks such as Stryker, Zimmer Biomet Holdings, and Organogenesis Holdings. According to TipRanks, Zimmerman has an average return of -0.6% and a 40.80% success rate on recommended stocks.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Alcon with a $96.03 average price target, which is a 55.69% upside from current levels. In a report released on February 17, RBC Capital also reiterated a Buy rating on the stock with a CHF80.00 price target.

See the top stocks recommended by analysts >>

ALC market cap is currently CHF31.5B and has a P/E ratio of 34.68.

Read More on ALC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).